Vilin Bio Med
add_icon

Vilin Bio Med

32.10
-1.15
(-3.46%)
Market Cap
44.78 Cr
PE Ratio
207.81
Volume
12,000.00
Day High - Low
32.85 - 32.00
52W High-Low
38.40 - 16.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
44.78 Cr
EPS
0.16
PE Ratio
207.81
PB Ratio
2.01
Book Value
16.53
EBITDA
1.30
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
0.97
Debt to Equity
0.20
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
-4.97 %
Net Income Growth
-
Cash Flow Change
102.96 %
ROE
36.62 %
ROCE
13.73 %
EBITDA Margin (Avg.)
16.27 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
17
12
11
12
16
15
8
Expenses
16
11
10
10
15
14
7
EBITDA
1
1
1
3
1
1
2
Operating Profit %
5 %
7 %
7 %
21 %
5 %
5 %
8 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
1
1
1
1
0
Profit Before Tax
0
0
0
2
0
0
1
Tax
0
0
0
1
0
0
0
Net Profit
0
0
0
1
0
0
1
EPS in ₹
0.20
0.15
0.10
1.25
0.12
0.16
2.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
14
14
14
18
32
28
Fixed Assets
2
2
2
2
1
1
Current Assets
12
12
12
8
19
13
Capital Work in Progress
0
0
0
0
0
2
Investments
0
0
0
0
0
0
Other Assets
12
12
12
16
31
25
Total Equity & Liabilities
14
14
14
18
32
28
Current Liabilities
7
6
5
7
9
5
Non Current Liabilities
0
1
1
1
0
0
Total Equity
7
7
7
11
23
23
Reserve & Surplus
4
4
4
1
9
9
Share Capital
3
3
3
10
14
14

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
2
-6
Investing Activities
0
0
0
0
0
-1
Operating Activities
-2
-1
0
-2
-7
0
Financing Activities
2
1
-0
2
9
-5

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
90.45 %
64.52 %
64.52 %
64.09 %
63.89 %
63.89 %
63.89 %
63.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.45 %
32.80 %
33.84 %
34.47 %
34.18 %
33.49 %
33.55 %
33.95 %
Others
0.10 %
2.68 %
1.65 %
1.45 %
1.94 %
2.62 %
2.57 %
2.39 %
No of Share Holders
827
659
585
581
551
492
476
462

Technical Indicators

RSI(14)
Neutral
47.50
ATR(14)
Less Volatile
1.50
STOCH(9,6)
Neutral
36.82
STOCH RSI(14)
Oversold
16.84
MACD(12,26)
Bearish
-0.47
ADX(14)
Weak Trend
20.18
UO(9)
Bearish
48.10
ROC(12)
Downtrend And Accelerating
-6.14
WillR(14)
Oversold
-97.62